COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir

Apr 22, 2021

The study from 10 Brazilian cities adds to mounting evidence that the two drugs shouldn’t be used in the treatment of COVID-19.

Mary Van Beusekom | News Writer | CIDRAP News

Apr 22, 2021
The study from 10 Brazilian cities adds to mounting evidence that the two drugs shouldn’t be used in the treatment of COVID-19.Read More

Leave a Reply

Your email address will not be published.